Narwhal Bio
Pre-clinicalDevelops cell therapies for cancer and autoimmune diseases using engineered immune cells.
Founded
2021
Focus
Cell TherapyImmunologyOncology
About
Develops cell therapies for cancer and autoimmune diseases using engineered immune cells.
Funding History
1Total raised: $4.1M
Seed$4.1MDigitalis VenturesJun 15, 2023
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile